| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
136,863 |
75,705 |
$5.96M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
73,607 |
36,578 |
$3.46M |
| 90834 |
Psychotherapy, 45 minutes with patient |
21,169 |
9,844 |
$1.63M |
| D1110 |
Prophylaxis - adult |
21,065 |
10,064 |
$852K |
| D0120 |
Periodic oral evaluation - established patient |
11,841 |
7,707 |
$391K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
13,469 |
4,822 |
$388K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
16,039 |
4,381 |
$364K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
12,512 |
12,184 |
$266K |
| 90837 |
Psychotherapy, 53 minutes with patient |
2,992 |
1,386 |
$264K |
| D1120 |
Prophylaxis - child |
7,921 |
3,873 |
$249K |
| 90832 |
Psychotherapy, 30 minutes with patient |
3,625 |
1,938 |
$241K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
7,931 |
2,838 |
$231K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
2,604 |
1,757 |
$213K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
9,250 |
2,235 |
$205K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
1,592 |
1,546 |
$174K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
1,952 |
1,364 |
$166K |
| D2392 |
Resin-based composite - two surfaces, posterior, primary or permanent |
2,370 |
1,266 |
$164K |
| D0330 |
Panoramic radiographic image |
4,318 |
1,892 |
$137K |
| D0150 |
Comprehensive oral evaluation - new or established patient |
3,320 |
2,173 |
$112K |
| 90791 |
Psychiatric diagnostic evaluation |
1,246 |
699 |
$110K |
| 96127 |
|
21,075 |
16,499 |
$97K |
| D0140 |
Limited oral evaluation - problem focused |
2,335 |
1,551 |
$84K |
| D0274 |
Bitewings - four radiographic images |
3,279 |
1,718 |
$76K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
4,929 |
3,144 |
$75K |
| D2391 |
Resin-based composite - one surface, posterior, primary or permanent |
1,193 |
673 |
$68K |
| V2100 |
Sphere, single vision, plano to plus or minus 4.00, per lens |
1,524 |
875 |
$65K |
| 99443 |
|
1,340 |
645 |
$61K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,316 |
1,552 |
$56K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,152 |
3,274 |
$55K |
| 92340 |
Fitting of spectacles, except for aphakia; monofocal |
672 |
599 |
$55K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
788 |
745 |
$50K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
5,119 |
5,069 |
$50K |
| D7140 |
Extraction, erupted tooth or exposed root |
890 |
495 |
$46K |
| D0220 |
Intraoral - periapical first radiographic image |
1,829 |
738 |
$41K |
| V2020 |
Frames, purchases |
1,582 |
1,534 |
$40K |
| D1206 |
Topical application of fluoride varnish |
1,218 |
1,195 |
$34K |
| 90686 |
|
3,887 |
2,943 |
$33K |
| 99442 |
|
1,028 |
614 |
$31K |
| 99215 |
Prolong outpt/office vis |
551 |
249 |
$25K |
| V2200 |
Sphere, bifocal, plano to plus or minus 4.00d, per lens |
502 |
210 |
$25K |
| D0210 |
Intraoral - complete series of radiographic images |
568 |
338 |
$19K |
| D1208 |
Topical application of fluoride, excluding varnish |
1,169 |
1,169 |
$17K |
| 94760 |
|
1,116 |
392 |
$17K |
| D0272 |
Bitewings - two radiographic images |
1,031 |
591 |
$16K |
| 99441 |
|
527 |
328 |
$14K |
| 99406 |
|
956 |
364 |
$14K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
853 |
850 |
$13K |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
186 |
80 |
$13K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
254 |
150 |
$13K |
| D9995 |
|
359 |
180 |
$11K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
394 |
258 |
$10K |
| 36415 |
Collection of venous blood by venipuncture |
1,564 |
1,381 |
$10K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
177 |
118 |
$9K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
346 |
124 |
$8K |
| 92551 |
|
878 |
857 |
$8K |
| 98968 |
|
144 |
45 |
$7K |
| D2393 |
Resin-based composite - three surfaces, posterior, primary or permanent |
121 |
43 |
$6K |
| 0012A |
|
173 |
172 |
$6K |
| V2103 |
Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens |
107 |
84 |
$6K |
| 99188 |
|
679 |
549 |
$6K |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
359 |
155 |
$5K |
| 99205 |
Prolong outpt/office vis |
70 |
28 |
$5K |
| 90682 |
|
80 |
80 |
$5K |
| 0011A |
|
157 |
156 |
$4K |
| D1351 |
Sealant - per tooth |
112 |
27 |
$4K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
61 |
40 |
$4K |
| 99384 |
|
83 |
46 |
$3K |
| 99383 |
|
75 |
44 |
$3K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
102 |
39 |
$3K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
48 |
24 |
$2K |
| T1013 |
Sign language or oral interpretive services, per 15 minutes |
117 |
107 |
$2K |
| D0190 |
|
49 |
25 |
$2K |
| 0002A |
|
41 |
40 |
$2K |
| D1330 |
|
760 |
685 |
$2K |
| T2022 |
Case management, per month |
13 |
13 |
$1K |
| 90715 |
|
62 |
62 |
$1K |
| 99000 |
|
333 |
305 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
119 |
88 |
$1K |
| 0071A |
|
27 |
27 |
$988.10 |
| 0001A |
|
24 |
24 |
$928.74 |
| S0580 |
Polycarbonate lens (list this code in addition to the basic code for the lens) |
47 |
43 |
$878.38 |
| 90656 |
|
422 |
421 |
$818.72 |
| V2784 |
Lens, polycarbonate or equal, any index, per lens |
1,340 |
646 |
$750.00 |
| 99408 |
|
215 |
201 |
$611.85 |
| 82948 |
|
54 |
13 |
$593.62 |
| 99051 |
|
42 |
26 |
$589.62 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
155 |
148 |
$577.81 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
236 |
233 |
$562.14 |
| 83655 |
|
73 |
69 |
$550.50 |
| 90685 |
|
130 |
104 |
$488.24 |
| 0072A |
|
12 |
12 |
$476.43 |
| 99173 |
|
764 |
762 |
$312.51 |
| 90734 |
|
114 |
104 |
$244.38 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
24 |
24 |
$234.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
16 |
15 |
$230.86 |
| 90670 |
|
256 |
247 |
$226.32 |
| 90648 |
|
225 |
216 |
$192.43 |
| 86580 |
|
15 |
12 |
$180.11 |
| 90688 |
|
75 |
71 |
$173.86 |
| 90633 |
|
164 |
153 |
$163.44 |
| 82465 |
|
28 |
28 |
$117.28 |
| 90723 |
|
103 |
90 |
$108.96 |
| 85018 |
|
63 |
63 |
$79.48 |
| 80061 |
Lipid panel |
13 |
13 |
$70.11 |
| 81002 |
|
117 |
113 |
$59.09 |
| 90461 |
|
199 |
199 |
$58.66 |
| 84703 |
|
13 |
13 |
$16.69 |
| 3078F |
|
46 |
45 |
$0.00 |
| 90710 |
|
12 |
12 |
$0.00 |
| 3074F |
|
131 |
125 |
$0.00 |
| G8419 |
Bmi documented outside normal parameters, no follow-up plan documented, no reason given |
93 |
85 |
$0.00 |
| 90651 |
|
165 |
165 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
12 |
12 |
$0.00 |
| 90680 |
|
49 |
49 |
$0.00 |
| D4999 |
|
12 |
12 |
$0.00 |
| 3079F |
|
13 |
12 |
$0.00 |
| 90619 |
|
14 |
14 |
$0.00 |